Short Interest in Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) Declines By 24.1%

Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) was the recipient of a large drop in short interest during the month of August. As of August 15th, there was short interest totaling 138,500 shares, a drop of 24.1% from the July 31st total of 182,400 shares. Approximately 5.7% of the shares of the company are sold short. Based on an average trading volume of 149,000 shares, the days-to-cover ratio is presently 0.9 days. Based on an average trading volume of 149,000 shares, the days-to-cover ratio is presently 0.9 days. Approximately 5.7% of the shares of the company are sold short.

Analyst Upgrades and Downgrades

Separately, Wall Street Zen raised shares of Ekso Bionics to a “sell” rating in a report on Saturday, July 5th. Two research analysts have rated the stock with a Buy rating, Based on data from MarketBeat.com, the company presently has an average rating of “Buy” and a consensus price target of $562.50.

Ekso Bionics Stock Down 1.7%

EKSO opened at $4.05 on Wednesday. The stock has a market cap of $10.57 million, a price-to-earnings ratio of -0.61 and a beta of 1.02. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.57 and a current ratio of 2.38. The firm’s fifty day moving average is $3.60 and its 200 day moving average is $46.64. Ekso Bionics has a fifty-two week low of $2.73 and a fifty-two week high of $19.20.

Ekso Bionics (NASDAQ:EKSO) last posted its quarterly earnings results on Monday, July 28th. The company reported ($1.24) EPS for the quarter, missing analysts’ consensus estimates of ($1.20) by ($0.04). Ekso Bionics had a negative net margin of 75.66% and a negative return on equity of 86.60%. The business had revenue of $2.06 million for the quarter, compared to the consensus estimate of $4.31 million. During the same period in the prior year, the business earned ($0.13) earnings per share. On average, sell-side analysts forecast that Ekso Bionics will post -0.48 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

An institutional investor recently raised its position in Ekso Bionics stock. Armistice Capital LLC grew its stake in shares of Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) by 18.4% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,042,382 shares of the company’s stock after buying an additional 316,733 shares during the period. Armistice Capital LLC owned 7.03% of Ekso Bionics worth $823,000 as of its most recent filing with the Securities and Exchange Commission (SEC). 6.42% of the stock is owned by institutional investors and hedge funds.

About Ekso Bionics

Ekso Bionics Holdings, Inc designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets.